VANCOUVER, British Columbia, July 07, 2020 (GLOBE NEWSWIRE) -- Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V1) (the Company or Global Care) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that its portfolio company, ViraxClear, through its joint venture, Shanghai Biotechnology Devices Ltd. (SBD) has received approval on July 3rd, 2020 from El Instituto de Salud Pblica de Chile (ISP) for the distribution of COVID-19 Rapid Antibody Test Kits (Test Kits) supplied by its previously disclosed manufacturing partners, Innovita Biological Technology Co., Ltd and Vazyme Biotech Co., Ltd (Innovita, Vazyme), for the Chilean market. ViraxClear has signed a non-binding LOI with Biosonda Biotecnologia (Biosonda) for the distribution of up to 3 million Test Kits for the Chilean market, a contract valued at up to $17.25 million in gross revenue.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f21c6f66-8b2f-4b6c-a13d-fd8e9822d37b
Distribution Contract for Test Kits in Chile
ViraxClear has received initial orders for trials and market testing of their Test Kits for the Chilean market and manufacturing is expected to commence over the next 60 days. The LOI provides for a 60-day exclusivity period during which ViraxClear and Biosonda intend to sign a definitive agreement with a total contract value of up to $17.25 million.
Biosonda is a biotechnology company founded in Chile in 1992 by leading scientists. It is currently one of the main distribution companies of products for scientific research and clinical diagnosis in Chile, with a recognizable corporate image in the national market. Biosonda works with some of the top global brands in the clinical and diagnostic industries and handle everything from marketing, import, logistics, research and development and sales.
The Biosonda commercial department is made up of a sales force, with a high degree of specialization and extensive experience in the market made up of experts in molecular biology and immunology. They offer a technical service laboratory for equipment maintenance, repair and training, a personalized after-sales service, and a commercial-logistics team that manages the tasks of quotation, import, logistics, inventory, orders and dispatch to provide an optimum service.
Alex Somjen, CEO of Global Care Capital Inc., stated, This distribution deal represents the culmination of months of negotiating by ViraxClear with top distributors in key global regions. Biosonda is in a perfect position to roll out mass testing for the region with Chile already seeing 288,000 confirmed cases of COVID-19 and the population requiring Antibody Testing once the curve has flattened.
ISP Approval
The Chilean government require medical testing devices to receive ISP Approval before they can be sold in Chile. Both Innovita and Vazyme, ViraxClear suppliers, are now on the list of ISP Approved factories, allowing ViraxClear tests to be imported and sold nationally.
Established in 2006, Innovita is a Chinese high-tech enterprise specialized in R&D, manufacturing, marketing and after-sales service of In-vitro diagnostic tests. The CE and NMPA (formerly known as CFDA) approved Innovita serology tests have performed particularly well during preliminary clinical tests carried out by the COVID-19 Testing Project; a multidisciplinary team of researchers and physicians at UCSF, UC Berkeley, Chan Zuckerberg Biohub and Innovative Genetics Institute. According to their studies, Innovita tests scored a 96.3 % specificity (NPV); 83.3% Sensitivity (PPV) with an IN-HOUSE ELISA test (gold reference standard) giving 99.1 % specificity (NPV); 81.8 % Sensitivity (PPV): https://covidtestingproject.org/
Vazyme, which isa highly reputable producer of enzymes and antibodies with products covering clinical diagnosis, molecular diagnostics, high-throughput sequencing and life science research, as well as RNA sequencing, enabling customers and reagent manufacturers to get enzymes with higher resistance. Vazyme owns a dedicated 8000 m2 R&D site and have established the Biotechnology Industry Research Institute, which is comprised of a team of nearly 100 scientists.
The Test Kits are intended for the qualitative detection of IgG and IgM antibodies against 2019 Novel Coronavirus, produced by the immune system after virus infection. IgM is the earliest antibody that appears upon the first immune response, with detection indicating an early stage infection. IgG is produced later and lasts a long time in the body, indicating a prior infection. The combination of the two markers offers an insight into what stage the virus has reached.
About ViraxClear
ViraxClear focuses on commercializing novel products that address significant healthcare needs with a specifictarget on the novel coronavirus (COVID-19). The companys main focus is marketing its ViraxClear Rapid IgM-IgG Combined Antibody Test. The ViraxClear Rapid IgM-IgG Combined Antibody Test for COVID-19 is a lateral flow immunoassay used to qualitatively detect both earlyand late marker IgG/IgM antibodies.
About Global Care
Global Care Capital is a global investment company which specializes in providing early stage financing to private and public companies. The Company engages in new, early stage investment opportunities in previously underdeveloped assets and obtaining positions in early stage investment opportunities that adequately reflect the risk profile.
GLOBAL CARE CAPITAL INC.:
Company Contact:
Alex Somjen, President & CEO
Neither the CSE nor its regulation services provider accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Information: This news release includes certain statements that may be deemed forward-looking statements. The use of any of the words anticipate, continue, estimate, expect, may, will, would, project, should, believe and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Companys disclosure documents which can be found under the Companys profile on http://www.sedar.com
- Researchers Uncover One Million New Components of the Human Genome - India Education Diary - February 18th, 2024
- Ancient retroviruses played a key role in the evolution of vertebrate brains - EurekAlert - February 18th, 2024
- New Scientific Reports publication reveals major difference in genomes of American and Chinese chestnut - EurekAlert - January 17th, 2024
- The Crucial Role of Molecular Biology in Cancer Therapy: A Comprehensive Review - Cureus - January 17th, 2024
- Cells of the future: A key to reprogramming cell identities - EurekAlert - December 22nd, 2023
- Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany - Marketscreener.com - April 7th, 2023
- Molecular Genetics and Metabolism | Journal - ScienceDirect - December 11th, 2022
- People don't mate randomly but the flawed assumption that they do is an essential part of many studies linking genes to diseases and traits - The... - November 25th, 2022
- Molecular and Cell Biology and Genetics - Master of Science / PhD ... - October 7th, 2022
- NIPD Genetics: Leading Genetic Testing Company - October 7th, 2022
- Skeletal Biology and Regeneration Students Recognized For Research Excellence - UConn Today - University of Connecticut - October 7th, 2022
- Mary Munson elected fellow of the American Society for Cell Biology - UMass Medical School - October 7th, 2022
- Every Body's Talking at Them: an Interview with Jon Lieff - CounterPunch - October 7th, 2022
- TriBeta invites students to explore opportunities to work with faculty at research fair on Oct. 11 - Ohio University - October 7th, 2022
- Genetics: the Vatican Does Not Intend to Be Behind the Times - FSSPX.News - October 7th, 2022
- Yield10 Bioscience Appoints Willie Loh, Ph.D., to the Board of Directors - citybiz - October 7th, 2022
- Molecular pathways of major depressive disorder converge on the synapse | Molecular Psychiatry - Nature.com - October 7th, 2022
- Sigyn Therapeutics Strengthens Board of Directors With the Appointments of Richa Nand, Jim Dorst and Christopher Wetzel - Yahoo Finance - October 7th, 2022
- UTHSC Researcher Co-Leads Study of Genes that Modulate Aging, Lifespan - UTHSC News - UTHSC News - October 7th, 2022
- GATC Health Investor Conference to Feature First Public Demonstration of Its AI Platform's Drug Discovery Capabilities - PR Newswire - October 7th, 2022
- Three Professors Conferred Tenure and Eleven Promoted - Wesleyan Argus - October 7th, 2022
- Who will get the call from Stockholm? It's time for STAT's 2022 Nobel Prize predictions - STAT - October 7th, 2022
- Dalhousie to present exhibition celebrating Gerhard Herzberg and his legacy - Dal News - October 7th, 2022
- Why Some People Should Rethink Their Morning Cup Of Coffee - Health Digest - October 7th, 2022
- Cell and Gene Therapy: Rewriting the Future of Medicine - Technology Networks - October 7th, 2022
- UofL researchers lead the call to increase genetic diversity in immunogenomics - uoflnews.com - July 6th, 2021
- In Brief This Week: Foundation Medicine, Myriad Genetics, Genetron Health, and More - GenomeWeb - July 6th, 2021
- More filling? Tastes great? How flies, and maybe people, choose their food - Yale News - July 6th, 2021
- Genetic mapping of subsets of patients with fragile X syndro | TACG - Dove Medical Press - July 6th, 2021
- What is The Babydust Method? Danielle Lloyd swears method helped her conceive girl - The Mirror - July 6th, 2021
- Datar Cancer Genetics joins hands with US based Iylon Precision Oncology to offer personalized Precision Oncology cancer treatment solutions - PR Web - July 6th, 2021
- Mapping a pathway to competitive production - hortidaily.com - hortidaily.com - July 6th, 2021
- Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. - Physician's Weekly - July 6th, 2021
- Global Genomics Market | Rising Incidence of Chronic and Genetic Diseases are Key Factors to Grow Market During 2021-2029 | 23andMe, Agilent... - July 6th, 2021
- The Babydust Method Danielle Lloyd used to conceive a girl after four sons and how it works - RSVP Live - July 6th, 2021
- In the beginning science and faith - The Irish Times - June 24th, 2021
- Ancient Maya Maintained Native Tropical Forest Plants around Their Water Reservoirs | Archaeology - Sci-News.com - June 24th, 2021
- Local foundation awards $1.25 million to MIND Institute to study rare genetic condition - UC Davis Health - June 24th, 2021
- Xlife Sciences AG: Collaboration with the University of Marburg - Yahoo Finance - June 24th, 2021
- Genetics diagnostics in India is on the verge of transformation: Neeraj Gupta, Founder and CEO of Genes2me - The Financial Express - June 24th, 2021
- Precision Medicine: Improving Health With Personalized Solutions - BioSpace - June 24th, 2021
- Half of Portland areas 22 top National Merit winners hail from just 2 schools - OregonLive - June 24th, 2021
- Investing in stem cells, the building blocks of the body - MoneyWeek - June 24th, 2021
- New study finds low levels of a sugar metabolite associates with disability and neurodegeneration in multiple sclerosis - Newswise - May 14th, 2021
- Cernadas-Martn Is a Champion for Marine and Human Diversity | | SBU News - Stony Brook News - May 14th, 2021
- Four Penn Faculty: Election to the National Academy of Sciences - UPENN Almanac - May 14th, 2021
- Is there a difference between a gene-edited organism and a 'GMO'? The question has important implications for regulation - Genetic Literacy Project - May 14th, 2021
- 5 Students Inducted Into American Society for Biochemistry and Molecular Biology Honor Society - Wesleyan Connection - May 14th, 2021
- The Science of Aliens, Part 2: What Kind of Genetic Code Would Extraterrestrials Have? - Air & Space Magazine - May 14th, 2021
- UT Austin Faculty Member Receives 2021 Piper Professor Award - Office of the Executive Vice President and Provost - UT News | The University of Texas... - May 14th, 2021
- Distinguished University of Birmingham plant scientist elected to the Royal Society - University of Birmingham - May 14th, 2021
- Double Hoo Research: Undergrads and Grads Team Up to Create Knowledge - University of Virginia - May 14th, 2021
- Global Genetic Testing Market Top Countries Analysis and Manufacturers With Impact of COVID-19 | 2021-2028 Detail Analysis focusing on Application,... - May 14th, 2021
- Morag Park named to the Order of Quebec - McGill Reporter - McGill Reporter - May 14th, 2021
- Third Rock Ventures Launches Flare Therapeutics With $82 Million Series A - BioSpace - May 14th, 2021
- The Royal Society announces election of new Fellows 2021 - Cambridge Network - May 14th, 2021
- Researchers Decode the "Language" of Immune Cells - Technology Networks - May 14th, 2021
- RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map -... - May 14th, 2021
- Mice Sperm Sabotage Other Swimmers With Poison | Smart News - Smithsonian Magazine - February 14th, 2021
- Study Identifies Never-Before-Seen Dual Function in Enzyme Critical for Cancer Growth - Newswise - February 14th, 2021
- Devious sperm 'poison' their rivals, forcing them to swim in circles until they die - Livescience.com - February 14th, 2021
- More needs to be done to find and fight COVID-19 variants, says Colorado researcher - FOX 31 Denver - February 14th, 2021
- Selfish sperm genes 'poison' the competition for the win - Big Think - February 14th, 2021
- Some sperm cells swim faster and even poison their competition to climb to the top - ZME Science - February 14th, 2021
- We are scientists: U of T researchers reach out to girls and women around the world - News@UofT - February 14th, 2021
- Mutations in frogs point to autism genes' shared role in neurogenesis - Spectrum - February 14th, 2021
- Global Genetic Testing Market Insights, Size Estimation, Research Insights, COVID-19 Impact and Future Trends By 2028 KSU | The Sentinel Newspaper -... - February 14th, 2021
- Acer Therapeutics Announces Topline Results from its Bioequivalence Trial of ACER-001 Compared to BUPHENYL Under Fed Conditions - GlobeNewswire - February 14th, 2021
- GeneSight Psychotropic Test's Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels... - February 14th, 2021
- Gu Ailing Eileen: I've learned to win for myself, not other people - Olympic Channel - February 14th, 2021
- Model organisms are more than just monkeys and mice - DW (English) - February 7th, 2021
- Dascena Strengthens Executive Leadership Team with Key Appointments and Promotion - Business Wire - February 7th, 2021
- PLUs Lathiena Nervo discusses her work and being named one of the 1,000 inspiring Black scientists in America - Pacific Lutheran University - February 7th, 2021
- Bioinformatics Services Market | Know the Latest Innovations and Future Market Scope - BioSpace - February 7th, 2021
- Plants May Be Able To Control the Genetics of Their Microbial Symbionts - Technology Networks - February 7th, 2021
- Risk Factor For Bacterial And Viral Co-Infection Uncovered - Forbes - February 7th, 2021
- The mistrusted medical miracle: Vaccines have revolutionized health, but some still question their safety - Charleston Gazette-Mail - February 7th, 2021
- US rushes to catch up in the race to detect mutant viruses - WWLTV.com - February 7th, 2021
- Of a Feather: When cousins are two of a kind - eagletimes.com - February 7th, 2021
- Beyond DNA: The rest of the story - Science Magazine - February 7th, 2021